North America Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 – 2028

North America Facial Aesthetics Market Size, Share & Industry Trends Analysis Report By Product (Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels), By Application, By End User, By Country and Growth Forecast, 2022 – 2028

The North America Facial Aesthetics Market would witness market growth of 13.7% CAGR during the forecast period (2022-2028).

For facial aesthetics, a variety of products are available, including chemical peels, cosmetic implants, dermal fillers, Botulinum toxin, and microdermabrasion. The applications of facial aesthetic therapy comprise lip augmentation, facial line correction, scar treatment, wrinkle reduction, and face lifting. Scars, blemishes, and facial wrinkles can all be diminished with laser skin resurfacing. Microdermabrasion is a minimally invasive process used to enhance the overall tone and texture of the skin.

This procedure has several advantages and uses a modestly harsh device to carefully remove the thicker, uneven outer layer. Additionally, a rise in young people's self-awareness regarding physical attractiveness fuels the need for facial aesthetic treatments. Increased sedentary behavior among young people also contributed to appearance problems, like facial hair and pigmentation, making them more self-conscious and driving up demand for facial aesthetic procedures.

Governments in regional countries are continuously working on the improvement of their healthcare infrastructure. For example, according to the Canadian Institute for Health Information, the United States spends more than any other country on healthcare services. On average, it spends more per person than the other OECD nations. These expenses are paid for by a diverse range of public payers, including the state, federal, and local governments, private insurance, and individual contributions. There is not a solitary national health insurance program.

The US market dominated the North America Facial Aesthetics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,004.9 million by 2028. The Canada market is poised to grow at a CAGR of 16.3% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 15.3% during (2022 - 2028).

Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.

Scope of the Study

Market Segments covered in the Report:

By Product

  • Dermal fillers
  • Botulinum toxin
  • Microdermabrasion
  • Chemical peels
  • Others
By Application
  • Facial line correction treatment
  • Scar treatment
  • Lip enhancement
  • Restoration of volume or Fullness
  • Others
By End User
  • Hospitals
  • Specialty & Dermatology Clinics
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • AbbVie, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Galderma S.A.
  • Candela Medical Corporation (Syneron Medical Ltd.)
  • Teoxane S.A.
  • Johnson & Johnson
  • Cynosure, LLC
  • Bausch Health Companies, Inc.
  • Ipsen Pharma Biotech SAS
  • Fotona D.o.o.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Facial Aesthetics Market, by Product
1.4.2 North America Facial Aesthetics Market, by Application
1.4.3 North America Facial Aesthetics Market, by End User
1.4.4 North America Facial Aesthetics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2020, Jan – 2022, Mar) Leading Players
Chapter 4. North America Facial Aesthetics Market by Product
4.1 North America Dermal fillers Market by Country
4.2 North America Botulinum toxin Market by Country
4.3 North America Microdermabrasion Market by Country
4.4 North America Chemical peels Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Facial Aesthetics Market by Application
5.1 North America Facial line correction treatment Market by Country
5.2 North America Scar treatment Market by Country
5.3 North America Lip enhancement Market by Country
5.4 North America Restoration of volume or Fullness Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Facial Aesthetics Market by End User
6.1 North America Hospitals Market by Country
6.2 North America Specialty & Dermatology Clinics Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Facial Aesthetics Market by Country
7.1 US Facial Aesthetics Market
7.1.1 US Facial Aesthetics Market by Product
7.1.2 US Facial Aesthetics Market by Application
7.1.3 US Facial Aesthetics Market by End User
7.2 Canada Facial Aesthetics Market
7.2.1 Canada Facial Aesthetics Market by Product
7.2.2 Canada Facial Aesthetics Market by Application
7.2.3 Canada Facial Aesthetics Market by End User
7.3 Mexico Facial Aesthetics Market
7.3.1 Mexico Facial Aesthetics Market by Product
7.3.2 Mexico Facial Aesthetics Market by Application
7.3.3 Mexico Facial Aesthetics Market by End User
7.4 Rest of North America Facial Aesthetics Market
7.4.1 Rest of North America Facial Aesthetics Market by Product
7.4.2 Rest of North America Facial Aesthetics Market by Application
7.4.3 Rest of North America Facial Aesthetics Market by End User
Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.1 Recent strategies and developments:
8.1.1.1 Acquisition and Mergers:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Partnerships, Collaborations, and Agreements:
8.2.2.2 Product Launches and Product Expansions:
8.3 Galderma S.A.
8.3.1 Company Overview
8.3.2 Recent strategies and developments:
8.3.2.1 Partnerships, Collaborations, and Agreements:
8.3.2.2 Approvals and Trials:
8.3.2.3 Acquisition and Mergers:
8.4 Candela Medical Corporation (Syneron Medical Ltd.)
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Acquisition and Mergers:
8.4.2.2 Geographical Expansions:
8.5 Teoxane S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Partnerships, Collaborations, and Agreements:
8.5.2.2 Approvals and Trials:
8.6 Johnson and Johnson
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental &Regional Analysis
8.6.4 Research & Development Expenses
8.7 Cynosure, LLC
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.8 Bausch Health Companies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.9 Ipsen Pharma Biotech SAS
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Fotona D.o.o.
8.10.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings